Search

Your search keyword '"Bonilla, G."' showing total 596 results

Search Constraints

Start Over You searched for: Author "Bonilla, G." Remove constraint Author: "Bonilla, G."
596 results on '"Bonilla, G."'

Search Results

1. Survival and Risk Factors Associated with Mortality in Patients with Sleep Apnoea in Colombia: A Retrospective Cohort Study

2. Open data from the third observing run of LIGO, Virgo, KAGRA and GEO

3. Development of a Methodology for Educational Management Entailing Government, Economic Sectors, and Educational Institutions for Sustainable Development

4. Immunoglobulins in systemic sclerosis management. A large multicenter experience

5. Description of Sheep Pox Outbreak in Spain in 2022–2023: Challenges Found and Lessons Learnt in Relation with Control and Eradication of This Disease

6. AB0159 CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE NOCIPLASTIC-BASED FIBROMYALGIA FEATURES (Nff) DIAGNOSTIC TOOL IN MEXICAN FIBROMYALGIA PATIENTS

7. AB1008 BRIDGING THE GAP BETWEEN PATIENT’S PERCEPTION ON QUALITY OF LIFE AND DISEASE ACTIVITY AND DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

8. POS0689 WINDOW OF OPPORTUNITY IN THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE WITH ABATACEPT. NATIONAL MULTICENTER STUDY OF 526 PATIENTS

9. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain

10. Aportaciones del registro de lupus de la Sociedad Española de Reumatología (RELESSER) al conocimiento del lupus eritematoso sistémico en España

13. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)

14. Open Data from the Third Observing Run of LIGO, Virgo, KAGRA, and GEO

15. Description of Sheep Pox Outbreak in Spain in 2022–2023: Challenges Found and Lessons Learnt in Relation with Control and Eradication of This Disease.

17. POS0035 INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT

18. POS0835 EFFECTIVENESS AND SAFETY OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 57 PATIENTS

19. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

20. OP0126 LONG-TERM FOLLOW UP OF ABATACEPT IN USUAL INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 172 PATIENTS

21. AB1677 VALIDATION ANALYSIS OF THE PHYSICIAN GLOBAL ASSESSMENT (PGA) SCALE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDED IN RELESSER-PROS REGISTRY

22. POS1508 PREVALENCE OF REMISSION ACCORDING TO PHYSICIAN AND PATIENT AND LEVEL OF AGREEMENT IN A REAL-WORLD MULTICENTER LUPUS REGISTRY

23. AB0594 CLINICAL SIGNIFICANCE OF ANTI-LA ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

24. POS1030 DNA-METHYLATION PROFILING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

25. POS0864 EFFECTIVENESS OF ANTIFIBROTICS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 50 PATIENTS IN CLINICAL PRACTICE

26. AB0585 COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)

27. AB0148 IDENTIFICATION OF CANDIDATE miRNA MOLECULES AS BIOMARKERS IN INTERSTITIAL PNEUMONIA WITH AN UNDERLYING AUTOIMMUNE DISEASE. A DISCOVERY COHORT FROM THE NEREA PROJECT

29. Encounter-based randomization did not result in contamination in a shared decision-making trial

30. PO.7.155 Study of the comorbidities present in the patients included in the registry of systemic lupus erythematosus of the spanish society of rheumatology (relesser)

32. Competitive and cost effective copper/low-k interconnect (BEOL) for 28 nm CMOS technologies

34. POS1427 CLINICAL COURSE IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES (IPAF): REAL-LIFE DATA FROM A MULTICENTER ILD REGISTRY

36. AB0376 DIFFERENCES IN IMMUNOGLOBULIN LEVELS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RHEUMATOID ARTHRITIS TREATED WITH RITUXIMAB

37. Recommendations from the ICM-VTE: General

38. Familiar and social influence on alcohol use of college youth

41. Carcinoma escamocelular del canal anal metastásico en un paciente con VIH tratado con quimiorradioterapia concomitante. Reporte de un caso y revisión de la literatura

42. PRESIÓN TRIBUTARIA EN BOGOTÁ

44. Evaluación del Funcionamiento de la Protección Diferencial 87 en Transformadores Monofásicos Ante Presencia de Fallas, Mediante un Prototipo Didáctico.

46. Recuperar la industria no es el objetivo del plan Recuperating industry is not the objective of the Plan

48. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up

49. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

50. ARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)

Catalog

Books, media, physical & digital resources